112 related articles for article (PubMed ID: 20513351)
1. Chromium attenuates high-fat diet-induced nonalcoholic fatty liver disease in KK/HlJ mice.
Chen WY; Chen CJ; Liu CH; Mao FC
Biochem Biophys Res Commun; 2010 Jul; 397(3):459-64. PubMed ID: 20513351
[TBL] [Abstract][Full Text] [Related]
2. Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice.
Chen WY; Chen CJ; Liu CH; Mao FC
Diabetes Obes Metab; 2009 Apr; 11(4):293-303. PubMed ID: 18721257
[TBL] [Abstract][Full Text] [Related]
3. Induction of non-alcoholic fatty liver disease and insulin resistance by feeding a high-fat diet in rats: does coenzyme Q monomethyl ether have a modulatory effect?
Safwat GM; Pisanò S; D'Amore E; Borioni G; Napolitano M; Kamal AA; Ballanti P; Botham KM; Bravo E
Nutrition; 2009; 25(11-12):1157-68. PubMed ID: 19592219
[TBL] [Abstract][Full Text] [Related]
4. Treatment of preestablished diet-induced fatty liver by oral fatty acid-bile acid conjugates in rodents.
Leikin-Frenkel A; Goldiner I; Leikin-Gobbi D; Rosenberg R; Bonen H; Litvak A; Bernheim J; Konikoff FM; Gilat T
Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1205-13. PubMed ID: 18989145
[TBL] [Abstract][Full Text] [Related]
5. SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats.
Aragno M; Tomasinelli CE; Vercellinatto I; Catalano MG; Collino M; Fantozzi R; Danni O; Boccuzzi G
Free Radic Biol Med; 2009 Oct; 47(7):1067-74. PubMed ID: 19616615
[TBL] [Abstract][Full Text] [Related]
6. Diabetes of the liver: the link between nonalcoholic fatty liver disease and HFCS-55.
Collison KS; Saleh SM; Bakheet RH; Al-Rabiah RK; Inglis AL; Makhoul NJ; Maqbool ZM; Zaidi MZ; Al-Johi MA; Al-Mohanna FA
Obesity (Silver Spring); 2009 Nov; 17(11):2003-13. PubMed ID: 19282820
[TBL] [Abstract][Full Text] [Related]
7. Prevention of diet-induced obesity by dietary isomerized hop extract containing isohumulones, in rodents.
Yajima H; Noguchi T; Ikeshima E; Shiraki M; Kanaya T; Tsuboyama-Kasaoka N; Ezaki O; Oikawa S; Kondo K
Int J Obes (Lond); 2005 Aug; 29(8):991-7. PubMed ID: 15852044
[TBL] [Abstract][Full Text] [Related]
8. Mukitake mushroom (Panellus serotinus) alleviates nonalcoholic fatty liver disease through the suppression of monocyte chemoattractant protein 1 production in db/db mice.
Nagao K; Inoue N; Inafuku M; Shirouchi B; Morooka T; Nomura S; Nagamori N; Yanagita T
J Nutr Biochem; 2010 May; 21(5):418-23. PubMed ID: 19423319
[TBL] [Abstract][Full Text] [Related]
9. Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet in rats.
Pan M; Song YL; Xu JM; Gan HZ
J Pineal Res; 2006 Aug; 41(1):79-84. PubMed ID: 16842545
[TBL] [Abstract][Full Text] [Related]
10. The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice.
Pinto Lde F; Compri CM; Fornari JV; Bartchewsky W; Cintra DE; Trevisan M; Carvalho Pde O; Ribeiro ML; Velloso LA; Saad MJ; Pedrazzoli J; Gambero A
Liver Int; 2010 Apr; 30(4):603-10. PubMed ID: 20088867
[TBL] [Abstract][Full Text] [Related]
11. High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice.
Tsuchiya H; Ebata Y; Sakabe T; Hama S; Kogure K; Shiota G
Metabolism; 2013 Jan; 62(1):62-9. PubMed ID: 22854109
[TBL] [Abstract][Full Text] [Related]
12. Weight gain induced by high-fat feeding involves increased liver oxidative stress.
Milagro FI; Campión J; Martínez JA
Obesity (Silver Spring); 2006 Jul; 14(7):1118-23. PubMed ID: 16899792
[TBL] [Abstract][Full Text] [Related]
13. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.
Hong XZ; Li LD; Wu LM
Clin Exp Pharmacol Physiol; 2007; 34(1-2):27-35. PubMed ID: 17201732
[TBL] [Abstract][Full Text] [Related]
14. Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice.
Coenen KR; Hasty AH
Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E492-9. PubMed ID: 17566116
[TBL] [Abstract][Full Text] [Related]
15. Lipid peroxidation is not a prerequisite for the development of obesity and diabetes in high-fat-fed mice.
Sohet FM; Neyrinck AM; Dewulf EM; Bindels LB; Portois L; Malaisse WJ; Carpentier YA; Cani PD; Delzenne NM
Br J Nutr; 2009 Aug; 102(3):462-9. PubMed ID: 19161640
[TBL] [Abstract][Full Text] [Related]
16. Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data.
Yki-Järvinen H
Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):709-14. PubMed ID: 20842026
[TBL] [Abstract][Full Text] [Related]
17. Nateglinide prevents fatty liver through up-regulation of lipid oxidation pathway in Goto-Kakizaki rats on a high-fat diet.
Mine T; Miura K; Kajioka T; Kitahara Y
Metabolism; 2008 Jan; 57(1):140-8. PubMed ID: 18078871
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
[TBL] [Abstract][Full Text] [Related]
19. Rosemary (Rosmarinus officinalis L.) leaf extract limits weight gain and liver steatosis in mice fed a high-fat diet.
Harach T; Aprikian O; Monnard I; Moulin J; Membrez M; Béolor JC; Raab T; Macé K; Darimont C
Planta Med; 2010 Apr; 76(6):566-71. PubMed ID: 19918713
[TBL] [Abstract][Full Text] [Related]
20. Dietary krill oil supplementation reduces hepatic steatosis, glycemia, and hypercholesterolemia in high-fat-fed mice.
Tandy S; Chung RW; Wat E; Kamili A; Berge K; Griinari M; Cohn JS
J Agric Food Chem; 2009 Oct; 57(19):9339-45. PubMed ID: 19761211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
